Redcliffe Labs, a Noida-based omnichannel diagnostics service provider, has successfully raised $42 million in a Series C funding round led by Denmark's Investment Fund for Developing Countries (IFU), which contributed $20 million, alongside LeapFrog Investments' $15 million. The funds will primarily be used to enhance access to affordable and high-quality diagnostics in Tier II and III cities across India by opening new labs, expanding the collection network, and increasing home collection services. Redcliffe Labs aims to democratize healthcare access, particularly for underserved populations, and has already made strategic acquisitions in North-Western India while exploring partnerships with other diagnostic chains. The company has also strengthened its leadership team with new appointments, including Ankur Shah as an Independent Director and Alka Saxena as CFO, both bringing extensive experience to the organization. Founder and CEO Aditya Kandoi emphasized that this funding is not just a financial milestone but a catalyst for transformative change in India's healthcare landscape. Through these efforts, Redcliffe Labs is committed to empowering individuals with the tools and knowledge needed to manage their health effectively.